Document is current
Any future updates will be listed below
-
Authors
Mahadevan, Daruka
Barve, Minal
Mahalingam, Devalingam
Parekh, Jay
Kurman, Michael
Strauss, James
Tremaine, Larry
Hromas, Robert
Sills, Joshua
McCulloch, John
Harkey, John
Suberg, Stacy
Zimmerman, Lisa
Zheng, Guangrong
Zhou, Daohong
-
Funding
Funding for this research was provided by:
Dialectic Therapeutics
- License Information
-
More Information
Article History
Received: 19 July 2025
Accepted: 14 October 2025
First Online: 12 November 2025
Declarations
:
: All relevant ethical regulations were followed during this study. The methods were performed in accordance with relevant guidelines and regulations and approved by the Food and Drug Administration (FDA). Written informed consent was obtained from all study participants. The Institutional Review Boards (IRBs) of all participating institutions approved the study protocol. The institutions participating in the study were Northwestern University Medical School, Chicago, IL; Mary Crowley Cancer Research, Dallas, TX; and Mays Cancer Center, UT Health San Antonio, TX.
: Not applicable.
: The authors declare no competing interests.
